000			01930 a2200541 4500
005			20250515041401.0
264		0	_c20061214
008			200612s 0 0 eng d
022			_a0009-9104
024	7		_a10.1111/j.1365-2249.2006.03188.x _2doi
040			_aNLM _beng _cNLM
100	1		_aMenzel, K
245	0	0	_aCathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. _h[electronic resource]
260			_bClinical and experimental immunology _cOct 2006
300			_a169-80 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCathepsin B _xantagonists & inhibitors
650	0	4	_aCathepsin D _xantagonists & inhibitors
650	0	4	_aCathepsin L
650	0	4	_aCathepsins _xantagonists & inhibitors
650	0	4	_aColitis _xdrug therapy
650	0	4	_aCysteine Endopeptidases _xbiosynthesis
650	0	4	_aCysteine Proteinase Inhibitors _xtherapeutic use
650	0	4	_aDipeptides _xtherapeutic use
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aGene Expression
650	0	4	_aHumans
650	0	4	_aInflammatory Bowel Diseases _xenzymology
650	0	4	_aIntestinal Mucosa _xenzymology
650	0	4	_aMacrophages _xenzymology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction _xmethods
700	1		_aHausmann, M
700	1		_aObermeier, F
700	1		_aSchreiter, K
700	1		_aDunger, N
700	1		_aBataille, F
700	1		_aFalk, W
700	1		_aScholmerich, J
700	1		_aHerfarth, H
700	1		_aRogler, G
773	0		_tClinical and experimental immunology _gvol. 146 _gno. 1 _gp. 169-80
856	4	0	_uhttps://doi.org/10.1111/j.1365-2249.2006.03188.x _zAvailable from publisher's website
999			_c16551013 _d16551013